ADLP PARTNER (EPA:ALP) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
ADLP PARTNER

BRIEF

published on 10/23/2024 at 11:42, 28 days 23 hours ago

Threshold crossing by Independence AM in DEKUPLE

Acquisition Euronext Paris Threshold Crossing AM Independence DEKUPLE Actions
BRIEF

published on 08/30/2024 at 18:05, 2 months 21 days ago

DÉKUPLE Reports Strong First-Half Performance for 2024

Gross Margin Data Marketing Consulting Services Digital Growth AI Investment
PRESS RELEASE

published on 08/30/2024 at 18:00, 2 months 21 days ago

Dékuple: 2024 FIRST-HALF BUSINESS
DÉKUPLE Group reports strong first-half business results for 2024 with net sales of €104.6m (+8.8%) and significant gross margin growth in digital marketing (+18.6%)

Digital Marketing Net Sales DÉKUPLE Group First-half Business Gross Margin Growth
BRIEF

published on 07/09/2024 at 18:35, 4 months 11 days ago

DÉKUPLE announces the acquisition of Ereferer by Rocket Marketing

Acquisition Digital Marketing Networking DÉKUPLE
PRESS RELEASE

published on 07/09/2024 at 18:30, 4 months 11 days ago

DÉKUPLE announces the acquisition of Ereferer, an automated netlinking platform, by Rocket Marketing
DÉKUPLE's subsidiary Rocket Marketing acquires Ereferer, an automated netlinking platform, enhancing its Brand Content and Netlinking services. The strategic move solidifies DÉKUPLE's position as a leader in data marketing

Data Marketing DÉKUPLE Ereferer Rocket Marketing Netlinking Platform
BRIEF

published on 06/14/2024 at 18:35, 5 months 6 days ago

Dékuple: Combined General Meeting on 14 June 2024

Share Buyback Dividend General Meeting Resolutions Auditors
PRESS RELEASE

published on 06/14/2024 at 18:30, 5 months 6 days ago

Dékuple: COMBINED GENERAL MEETING ON 14 JUNE 2024
ADLPartner's Combined General Meeting on 14 June 2024 approves €1.04 per share dividend and raises share buyback program price to 45 euros

Share Buyback Program Dividend Price Increase Combined General Meeting ADLPartner
BRIEF

published on 05/22/2024 at 20:05, 5 months 29 days ago

DÉKUPLE announces three new collective share retention commitments

ADLPartner DÉKUPLE Collective Commitments Retention Of Shares Article 787B

Accesswire

Published on 11/21/2024 at 10:03, 57 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 25 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 35 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:56, 3 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 30 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 55 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 58 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 1 hour ago

Nabaltec AG continues solid earnings performance in third quarter of 2024

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 2 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 40 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 15 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 15 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE